Leading Cloud-Based AI for Life Sciences | AI for Healthcare

Digital Transformation of Safety Vigilance We are
COMPREHENSIVE

Transform the safety vigilance of your Life Sciences and Health Care products with our advanced AI Safety Platform. Our integrated modular Multi-Vigilance Platform caters to Pharma, Cosmetics, Devices, and Vaccines, offering streamlined safety solutions that drive efficiency, accuracy, and rapid insights.

 Leading Cloud-Based AI for Life Sciences | AI for Healthcare

60% Reduction in Implementation Time

AI augmented Safety Vigilance for Drugs, Cosmetics & Medical Devices | Transforming Pharmacovigilance and Drug Safety with AI

40% Reduction in Total Cost

AI augmented Safety Vigilance for Drugs, Cosmetics & Medical Devices | Transforming Pharmacovigilance and Drug Safety with AI

3X Efficiency with Process Automation

AI augmented Safety Vigilance for Drugs, Cosmetics & Medical Devices | Transforming Pharmacovigilance and Drug Safety with AI

Anywhere-Any Cloud Deployment

We help organisations gain valuable insights to make informed decisions from their data in the most effective manner.

According to industry research, 80% of the data is not being used as a strategic asset in the life sciences and healthcare domain.

Key challenges we solve:

 Leading Cloud-Based AI for Life Sciences | AI for Healthcare | data foundry1

Regulatory Risks triggered by scattered data in legacy systems.

  • $10BN
    PV penalties/year
  • $7BN
    faulty labels penalties
  • $2M
    per product per region
 Leading Cloud-Based AI for Life Sciences | AI for Healthcare | data foundry2

Ineffective Signal Detection & Management

  • $43M
    cost per major safety compliance failure
  • $11.2B
    paid annually in global pharma non-compliance fines
  • $20M
    to remediate a single regulatory warning or consent decree
 Leading Cloud-Based AI for Life Sciences | AI for Healthcare | data foundry3

Inability to accurately predict future outcomes that can be trusted.

  • $250M
    per product recall
  • $450BN
    in frauds

Opportunity to Improve Safety Vigilance Processes

Across the life sciences industry, major players are grappling with billions of dollars in product recalls, labelling issues, and failed clinical trials attributed to safety concerns. The pressing need for transformation in safety vigilance practices has never been more evident. Digital transformation is critical to driving automation and elevating data quality in the key area of Safety Vigilance, a challenge that comes with many obstacles.

 Leading Cloud-Based AI for Life Sciences | AI for Healthcare

High cost of data transformation

AI augmented Safety Vigilance for Drugs, Cosmetics & Medical Devices | Transforming Pharmacovigilance and Drug Safety with AI

Long cycle time to realise benefits

AI augmented Safety Vigilance for Drugs, Cosmetics & Medical Devices | Transforming Pharmacovigilance and Drug Safety with AI

Organisational change management

Transforming Life Sciences with Data Digitalization and AI-Powered Automation

As a premier technology company focused on using data and automation for ensuring safer products and better health outcomes, we cater to pharmaceutical, medical devices, cosmetics, nutraceuticals, CROs and research institutions. Our specialized solutions eradicate manual processes, slashing costs and timeframes. Embrace data-driven automation for decisive analysis, precise conclusions, and a competitive edge.

AI augmented Safety Vigilance for Drugs, Cosmetics & Medical Devices | Transforming Pharmacovigilance and Drug Safety with AI

Experience Insights and Automation
Like Never Before

At Datafoundry, we're more than just a solution provider. We're your partner in achieving data-driven excellence. Our AI-powered insights and automation propel you towards faster, more informed decisions. Maximize your competitive advantage and embark on a journey of transformation with Datafoundry.


Partner with Datafoundry

Awards & Recognitions

AI augmented Safety Vigilance for Drugs, Cosmetics & Medical Devices | Transforming Pharmacovigilance and Drug Safety with AI

World’s Most Innovative AI Tools - 2023

AI augmented Safety Vigilance for Drugs, Cosmetics & Medical Devices | Transforming Pharmacovigilance and Drug Safety with AI

Best use of Machine Learning 2023

AI augmented Safety Vigilance for Drugs, Cosmetics & Medical Devices | Transforming Pharmacovigilance and Drug Safety with AI

Top 10 Data Science Startups in India for 2023

AI augmented Safety Vigilance for Drugs, Cosmetics & Medical Devices | Transforming Pharmacovigilance and Drug Safety with AI

NASSCOM’s AI Gamechangers Award 2022

AI augmented Safety Vigilance for Drugs, Cosmetics & Medical Devices | Transforming Pharmacovigilance and Drug Safety with AI

10 Most Recommended AI Startups - 2019

Resources

News Events

Join Datafoundry at NASSCOM Global Confluence 2025: Forging Global Alliances for Tech Leadership

During this symposium, industry, healthcare providers, pharmacy professionals, regulators, and academics will share their insights on topics like the current pharmacovigilance requirements, upcoming changes in the regulations, global and local pharmacovigilance practices, opportunities, challenges in effective management of pharmacovigilance operations in India. Datafoundry is looking forward to being a part of this knowledge sharing platform, where we can discuss challenges, concerns, and issues, and find a solution for ensuring compliance to regulations, as well as ensure PV practices are more efficient and harmonized. Datafoundry is excited to participate in NASSCOM Global Confluence 2025, a landmark event bringing together global tech leaders, innovators, and changemakers to define the future of technology leadership and cross-border collaboration. This year’s theme, “Forging Global Alliances for Tech Leadership,” highlights the critical role of international partnerships in driving innovation, scaling DeepTech solutions, and unlocking new markets. Featured Session: Navigating the U.S. Market: Opportunities, Challenges & Future Prospects for Indian Tech This session delivers a sharp focus on the U.S. market — uncovering key opportunities, policy shifts, and growth strategies for Indian SMEs. Attendees will gain forward-looking insights to navigate 2025 and beyond, seize emerging opportunities, and establish a strong U.S. presence.
Read More right-arrow